News from accuray incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 17, 2023, 07:30 ET Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness

Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting...

Apr 26, 2023, 16:10 ET Accuray Reports Fiscal 2023 Third Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2023 ended March 31, 2023. Third Quarter Fiscal...

Apr 13, 2023, 16:30 ET Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2023, ended March 31, 2023, during a...

Mar 08, 2023, 07:35 ET Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33rd Annual Oppenheimer Healthcare Conference taking place March 13-15,...

Feb 21, 2023, 16:15 ET Accuray to Participate in the Cowen 43rd Annual Health Care Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 43rd Annual Health Care Conference taking place March 6-8, 2022....

Feb 16, 2023, 07:35 ET Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer

Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative...

Feb 07, 2023, 16:10 ET Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools...

Feb 01, 2023, 16:10 ET Robert C. Kill Joins Accuray Board of Directors

Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company's Board of Directors, effective as of January...

Feb 01, 2023, 16:10 ET Accuray Reports Fiscal 2023 Second Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2023 ended December 31, 2022. Second Quarter...

Jan 26, 2023, 07:35 ET European Radiosurgery Center Munich Invests in Second Accuray CyberKnife® System to Support the Demand for High-Precision Radiosurgery Treatments

Accuray Incorporated (NASDAQ: ARAY) announced today that the European Radiosurgery Center Munich has selected a second CyberKnife® System, the latest ...

Jan 18, 2023, 16:05 ET Accuray to Report Second Quarter Fiscal 2023 Financial Results on February 1, 2023

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2023, ended December 31, 2022, after the...

Jan 17, 2023, 07:35 ET Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device

Accuray Incorporated (NASDAQ: ARAY) announced today that Auckland Radiation Oncology (ARO) is the first center in New Zealand to treat patients with...

Jan 10, 2023, 16:05 ET Accuray to Participate in the B. Riley Securities' 3rd Annual Oncology Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the B. Riley Securities' 3rd Annual Oncology Conference taking place January ...

Nov 28, 2022, 08:10 ET Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022

Accuray Incorporated (NASDAQ: ARAY) announced today that its commitment to delivering better, faster cancer treatment technology and superior service ...

Nov 16, 2022, 07:35 ET Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System

Accuray Incorporated (NASDAQ: ARAY) announced today that the Oscar Lambret Center in Lille, France has installed its second Radixact® System and the...

Nov 02, 2022, 16:07 ET Accuray Reports Fiscal 2023 First Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2023 ended September 30, 2022. First Quarter...

Nov 01, 2022, 07:35 ET Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration

Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system ...

Oct 26, 2022, 07:35 ET New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain

Accuray Incorporated (NASDAQ: ARAY) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved reimbursement for the ...

Oct 21, 2022, 12:00 ET GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy

GE Healthcare and Accuray Incorporated (NASDAQ: ARAY) announced today that they have signed a global commercial collaboration agreement designed to...

Oct 19, 2022, 16:05 ET Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2023, ended September 30, 2022, after the...

Oct 13, 2022, 07:35 ET Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

Accuray Incorporated (NASDAQ: ARAY) announced today the company, in partnership with C-RAD AB (NASDAQ Stockholm: CRAD B), will showcase an important...

Oct 11, 2022, 07:35 ET Data Published in The Lancet Oncology Indicate Men With Prostate Cancer Treated With the Accuray CyberKnife® Platform Experienced a Lower Incidence of Bladder Side Effects Than Those Treated With Conventional Linear Accelerators

Accuray Incorporated (NASDAQ: ARAY) announced today that results of the PACE-B – Prostate Advances in Comparative Evidence – trial were published in...

Oct 06, 2022, 16:05 ET Accuray to Host Meeting with Analysts and Investors at ASTRO on October 24, 2022

Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a key opinion leader (KOL) discussion with analysts and investors on...

Sep 30, 2022, 07:30 ET Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform...

Sep 30, 2022, 07:30 ET Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform...